Perspective Therapeutics, Inc. (CATX) Misses Q3 EPS by 3c

Perspective Therapeutics, Inc. (NYSE: CATX) reported Q3 EPS of ($0.35), $0.03 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $290 thousand versus the consensus estimate of $224.08 thousand.

For earnings history and earnings-related data on Perspective Therapeutics, Inc. (CATX) click here.

You May Also Be Interested In

• IMF chief says global economy weathered Iran war shock well
• Gartner, Inc. (IT) September 190 puts active, share price down 2.9%
• Popular stocks with increasing option volume: SPCX INTC MU PLTR MSTR SOFI NFLX SMCI MRNA HOOD AVGO WMT